Fundraising Fox
/Companies
Sign in

Cryoport

NASDAQ: CYRX

Lake Forest, US · Nevada corporation

Find your way into Cryoport

Sign up to see every warm intro you have to Cryoport

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cryoport team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Cryoport provides temperature-controlled supply chain solutions, cryogenic storage systems, and biostorage and sample processing services for the Life Sciences industry, with a focus on cell and gene therapy. It serves biopharmaceutical, animal husbandry, and reproductive medicine companies, as well as universities, research institutions, and government agencies across the Americas, EMEA, and APAC.

BiotechHealthtechLogistics & Supply Chain

Founders & leadership

RS
Robert StefanovichExecutiveRobert Stefanovich is an executive with extensive financial management and business leadership experience across life sciences and hi-tech organizations, ranging from startups to Fortune 500 companies. He has a background in public accounting and has managed strategic planning, fundraising, mergers and acquisitions, and SEC compliance for both publicly traded and privately held entities.
JWJerrell W. Shelton
Jerrell W. SheltonPresident, Chief Executive Officer and Chairman of the Board
MSMark Sawicki
Mark SawickiPresident and Chief Executive Officer of Cryoport Systems, LLC; Senior Vice President and Chief Scientific Officer of the Company
EJ
Edward J. ZecchiniChief Digital and Technology Officer

Board

RM
Ramkumar MandalamBoard director
RR
Richard RathmannBoard director
RB
Richard BermanBoard director

Reported raises · per SEC filings

Form D private placements

$29.2M disclosed across 5 rounds · 2014–2018

▶$25MraisedDec 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jerrell W SheltonExecutive Officer, Director
  • Richard J BermanDirector
  • Edward ZecchiniDirector
  • Ramkumar MandalamDirector
  • Robert S. StefanovichExecutive Officer
  • Robert HaririDirector
Offering amount
$25M
Amount sold
$25M
First sale
Dec 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedApr 2016 · 192 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert S. StefanovichExecutive Officer
  • Ramkumar MandalamDirector
  • Robert HaririDirector
  • Jerrell W SheltonExecutive Officer, Director
  • Edward ZecchiniDirector
  • Richard J BermanDirector
Offering amount
$2.5M
Amount sold
$2.5M
Sales commissions
$156K
Placement agents
Emergent Financial Group, Inc.
First sale
Apr 2016
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$46.2KraisedMar 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ramkumar MandalamDirector
  • Robert S. StefanovichExecutive Officer
  • Richard J BermanDirector
  • Jerrell W SheltonExecutive Officer, Director
  • Edward ZecchiniDirector
  • Robert HaririDirector
Offering amount
$46.2K
Amount sold
$46.2K
First sale
Mar 2016
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50KraisedMar 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ramkumar MandalamDirector
  • Richard RathmannDirector
  • Richard BermanDirector
  • Jerrell SheltonExecutive Officer, Director
  • Robert StefanovichExecutive Officer
  • Edward ZecchiniDirector
Offering amount
$4.8M
Amount sold
$50K
Sales commissions
$6.5K
Placement agents
Emergent Financial Group, Inc.
First sale
Feb 2015
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedMay 2014 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert StefanovichExecutive Officer
Offering amount
$9.6M
Amount sold
$1.6M
Sales commissions
$89.6K
Placement agents
Emergent Financial Group, Inc.
First sale
May 2014
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Cryoport do?
Cryoport provides temperature-controlled supply chain solutions, cryogenic storage systems, and biostorage and sample processing services for the Life Sciences industry, with a focus on cell and gene therapy. It serves biopharmaceutical, animal husbandry, and reproductive medicine companies, as well as universities, research institutions, and government agencies across the Americas, EMEA, and APAC.
How much funding has Cryoport raised?
Cryoport has disclosed $29.2M raised across 5 rounds.
Where is Cryoport headquartered?
Cryoport is headquartered in Lake Forest, US.